Bromoxol® is indicated for the treatment of respiratory disorders associated with productive cough. These include tracheobronchitis, bronchitis with emphysema, bronchiectasis, bronchitis with bronchospasm, chronic inflammatory pulmonary conditions, and pneumoconiosis.
Adults: The recommended daily dose is 2-4 teaspoonfuls, three times daily. Initially, 4 teaspoonfuls, three times daily, and then as required.
Children:
Under 2 years: ¼ teaspoonful, three times daily.
2-5 years: ½ teaspoonful, three times daily.
5-10 years: 1 teaspoonful, three times daily.
Bromoxol® is contraindicated in individuals with known hypersensitivity to Bromhexine HCl.
There are no known significant interactions with other medicines.
Gastrointestinal side effects may occur occasionally with Bromhexine, and a transient rise in serum aminotransferase values has been reported. Other reported adverse effects include headache, vertigo (dizziness), sweating, and allergic reactions.
Since mucolytics may disrupt the gastric mucosal barrier, Bromhexine should be used with caution in patients with a history of gastric ulceration. Care is also advisable in asthmatic patients.
Store in a cool, dry place below 30°C.
Protect from light.
Keep the container tightly closed.
Medicine: Keep out of reach of children.